経カテーテル大動脈弁置換術(TAVR)の世界市場2016-2020

◆英語タイトル:Global Transcatheter Aortic Valve Replacement Market 2016-2020
◆商品コード:IRTNTR8085
◆発行会社(調査会社):Technavio
◆発行日:2016年1月20日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,000 ⇒換算¥228,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD3,500 ⇒換算¥399,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、経カテーテル大動脈弁置換術(TAVR)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、経カテーテル大動脈弁置換術(TAVR)の世界市場規模及び予測、製品別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、コスト分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Transcatheter Aortic Valve Replacement

Transcatheter heart valve replacement systems are cardiovascular devices that repair the aortic valve without removing the old and damaged valves. It is used to treat aortic valve disorders such as regurgitation, aortic stenosis, and degeneration. TAVI is performed in two ways, transfemoral approach (through the femoral artery) and transapical approach (through a small chest incision).

Technavio’s analysts forecast the global TAVR market to grow at a CAGR of 16.9% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global TAVR market for the period 2015-2020. To calculate the market size, the report considers the revenue generated from the sales of transcatheter aortic valve implants.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Transcatheter Aortic Valve Replacement Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Edwards Lifesciences
• Medtronic
• Boston Scientific
• St. Jude Medical

[Other prominent vendors]
• Direct Flow Medical
• JenaValve Technology
• Meril Life Sciences
• Sorin
• SYMETIS

[Market driver]
• Rise in prevalence of aortic stenosis with increase in aging population
• For a full, detailed list, view our report

[Market challenge]
• Risk of potential complications
• For a full, detailed list, view our report

[Market trend]
• Focus on clinical trials
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Clinical trial studies on TAVR

PART 07: Cost analysis
• Cost analysis of aortic valve replacement procedures

PART 08: Market segmentation by product
• Transfemoral implantation
• Transapical implantation

PART 09: Geographical segmentation
• Global TAVR market by geography 2015-2020
• TAVR market in EMEA
• TAVR market in Americas
• TAVR market in APAC

PART 10: TAVR market in US
• TAVR market in the US

PART 11: Market drivers
• Rise in prevalence of aortic stenosis with increase in aging population
• Launch of novel transcatheter valve implants in US and Japan
• Increase in adoption of MI procedures

PART 12: Impact of drivers

PART 13: Market challenges
• Risk of potential complications
• Threat from surgical valve implant procedures
• Stringent regulations
• Lack of of skilled practitioners

PART 14: Impact of drivers and challenges

PART 15: Market trends
• Focus on clinical trials
• Development of TAVR technology and self-expandable stent frame
• Devices for a younger and lower-risk patient population

PART 16: Vendor landscape
• Competitive scenario
• Key vendor analysis
• Other prominent vendors

PART 17: Appendix
• List of abbreviation

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global TAVR market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Snapshot of TAVR device studies in clinical trials
Exhibit 05: Comparison of the cost involved in valve replacement procedures (high risk group)
Exhibit 06: Segmentation of TAVR market by product
Exhibit 07: Comparison of transfemoral and transapical implantation approaches
Exhibit 08: Global TAVR market by geography 2015
Exhibit 09: Global TAVR market by geography 2020
Exhibit 10: Segmentation global TAVR market by geography 2015-2020
Exhibit 11: TAVR market in EMEA 2015-2020 ($ millions)
Exhibit 12: TAVR market in Americas 2015-2020 ($ millions)
Exhibit 13: TAVR market in APAC 2015-2020 ($ millions)
Exhibit 14: TAVR market in US 2015-2020 ($ millions)
Exhibit 15: Pipeline snapshot of TAVR in US
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: TAVR systems with FDA approval 2011-2015
Exhibit 19: TAVR systems with CE mark approval 2007-2015
Exhibit 20: Product portfolio matrix for key vendors 2015
Exhibit 21: Market share analysis 2015
Exhibit 22: Edwards Lifesciences: Key takeaways
Exhibit 23: Medtronic: Key takeaways
Exhibit 24: Boston Scientific: Key takeaways
Exhibit 25: St. Jude Medical: Key takeaways



【掲載企業】

Edwards Lifesciences, Medtronic, Boston Scientific, St. Jude Medical, Direct Flow Medical, Meril Life Sciences, SYMETIS, JenaValve Technology, Sorin.

【レポートのキーワード】

経カテーテル大動脈弁置換術(TAVR)、大動脈弁置換術、心臓弁

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[経カテーテル大動脈弁置換術(TAVR)の世界市場2016-2020]販売に関する免責事項
★調査レポート[経カテーテル大動脈弁置換術(TAVR)の世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆